Skip to content

Search results for ""

Order
Filter by category

Transport committee to debate whether to study BC Ferries' Chinese ship contract

Transport committee to debate whether to study BC Ferries' Chinese ship contract

OTTAWA — The House of Commons transport committee is meeting to decide whether to study BC Ferries' decision to purchase four Chinese vessels.
Hundreds greet Nepal's ex-king on his birthday as support for the ousted monarch grows

Hundreds greet Nepal's ex-king on his birthday as support for the ousted monarch grows

KATHMANDU, Nepal (AP) — Hundreds of supporters of Nepal's former king lined up outside his residence to greet him on his 74th birthday Monday as support for the ousted monarch grows in the Himalayan nation.
What to Stream: Spielberg looks back at 'Jaws,' Clipse reunite and 'Bachelor in Paradise' is flirty

What to Stream: Spielberg looks back at 'Jaws,' Clipse reunite and 'Bachelor in Paradise' is flirty

Steven Spielberg reflecting on his shark blockbuster in the documentary “Jaws @ 50" and Clipse, the dynamic duo of Pusha T and Malice, returning for the album “Let God Sort Em Out” are some of the new television, films, music and games headed to a de
What to Stream: Spielberg looks back at 'Jaws,' Clipse reunite and 'Bachelor in Paradise' is flirty

What to Stream: Spielberg looks back at 'Jaws,' Clipse reunite and 'Bachelor in Paradise' is flirty

Steven Spielberg reflecting on his shark blockbuster in the documentary “Jaws @ 50" and Clipse, the dynamic duo of Pusha T and Malice, returning for the album “Let God Sort Em Out” are some of the new television, films, music and games headed to a de
What to Stream: Spielberg looks back at 'Jaws,' Clipse reunite and 'Bachelor in Paradise' is flirty

What to Stream: Spielberg looks back at 'Jaws,' Clipse reunite and 'Bachelor in Paradise' is flirty

Steven Spielberg reflecting on his shark blockbuster in the documentary “Jaws @ 50" and Clipse, the dynamic duo of Pusha T and Malice, returning for the album “Let God Sort Em Out” are some of the new television, films, music and games headed to a de
Indonesia's Mount Lewotobi Laki Laki volcano erupts and sends searing-hot ash miles high

Indonesia's Mount Lewotobi Laki Laki volcano erupts and sends searing-hot ash miles high

JAKARTA, Indonesia (AP) — Indonesia’s rumbling Mount Lewotobi Laki Laki erupted twice on Monday, sending a column of volcanic materials up to 18 kilometers (11 miles) into the sky, dumping ash on villages and causing flight cancellations.
Indonesia's Mount Lewotobi Laki Laki volcano erupts and sends searing-hot ash miles high

Indonesia's Mount Lewotobi Laki Laki volcano erupts and sends searing-hot ash miles high

JAKARTA, Indonesia (AP) — Indonesia’s rumbling Mount Lewotobi Laki Laki erupted twice on Monday, sending a column of volcanic materials up to 18 kilometers (11 miles) into the sky, dumping ash on villages and causing flight cancellations.
Indonesia's Mount Lewotobi Laki Laki volcano erupts and sends searing-hot ash miles high

Indonesia's Mount Lewotobi Laki Laki volcano erupts and sends searing-hot ash miles high

JAKARTA, Indonesia (AP) — Indonesia’s rumbling Mount Lewotobi Laki Laki erupted twice on Monday, sending a column of volcanic materials up to 18 kilometers (11 miles) into the sky, dumping ash on villages and causing flight cancellations.
Wegovy and Zepbound prices fall, but access to the obesity drugs still isn’t guaranteed

Wegovy and Zepbound prices fall, but access to the obesity drugs still isn’t guaranteed

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The medications still amount to around $500 per month for those without insurance — out of reach for many patients.
Wegovy and Zepbound prices fall, but access to the obesity drugs still isn’t guaranteed

Wegovy and Zepbound prices fall, but access to the obesity drugs still isn’t guaranteed

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The medications still amount to around $500 per month for those without insurance — out of reach for many patients.